Skip to main content
TipRanks
Go Ultimate75% OFF

22nd Century (XXII) AI Stock Analysis

1,813 Followers
XXII

22nd Century

(NASDAQ:XXII)

Select Model
Rating:42Neutral
Price Target:$0.38▲(13.39% Upside)
Action:reiterated
Date:11/20/26

Persistent losses and negative cash flow are the primary constraints, reinforced by a severe technical downtrend and weak valuation support. Improving quarterly operating trends, retail expansion, and available liquidity provide some upside potential but do not yet outweigh the company's financial and dilution risks.

Positive Factors
FDA-authorized low-nicotine nicheThe FDA-authorized VLN technology gives XXII a differentiated position in the reduced-nicotine combustible category. That regulatory status, combined with established manufacturing capabilities and intellectual property, may support brand credibility, retailer access, and durable customer adoption as distribution expands.
Negative Factors
Persistent losses and cash burnThe company has not yet demonstrated sustainable unit economics or internally funded growth. Negative gross profit, large operating losses, and ongoing cash consumption can force continued cost controls or external financing, limiting strategic flexibility until profitability and cash-flow breakeven are achieved.

22nd Century (XXII) vs. SPDR S&P 500 ETF (SPY)

-100%-75%-50%-25%0%25%50%XXII-100.00%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$137.32K
Dividend Yield
―
Average Volume (3M)
1.19M
Price to Earnings (P/E)
0.0
Beta (1Y)
2.98
Revenue Growth
-15.53%
EPS Growth
99.45%
Country
US
Employees
32
Sector
Consumer Defensive
Sector Strength
62
Industry
Tobacco

22nd Century Business Overview & Revenue Model

Company Description

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product se...

How the Company Makes Money

The company’s primary monetization approach has been generating revenue from the sale of tobacco products (including reduced-nicotine cigarettes) and from commercial arrangements tied to its plant-technology intellectual property (e.g., licensing, te...

22nd Century Earnings Call Summary

Earnings Call Date:Nov 16, 2026(Q3-2026)|% Change Since:-56.36%|Next Earnings Date:Mar 11, 2027
Earnings Call SentimentPositive

The call was predominantly positive. Management reported strong sequential revenue growth, improved gross profit and losses, a 166% increase in reported same-store sales for Pinnacle Pure branded products, expanding retail distribution, planned Gopuff access, simplified capitalization, and cash expected to fund operations well into 2027. These positives outweighed the nine-month revenue decline, ongoing losses, higher year-over-year operating expenses, modestly worse nine-month Adjusted EBITDA, and remaining distribution gaps.

Positive Updates

Third-Quarter Revenue Growth
Net revenues were $4.8 million in the third quarter of 2026, up 66% from $2.9 million in the second quarter and up 18.6% from $4 million in the third quarter of 2025.

Negative Updates

Nine-Month Revenue Decline
For the first nine months of 2026, net revenues were $11.7 million versus $14.1 million in the prior-year period, a decline management attributed to the planned exit of low- and negative-margin contract volume.

Company Guidance

Management expects the legacy CMO wind-down to be “substantially complete by the end of 2026,” expects the Gopuff initiative to “begin in the fourth quarter,” with the objective of establishing “a well-developed direct-to-consumer operating model as we enter 2027,” and said the company has sufficient cash to fund operations “well into 2027 based on management's current outlook,” with a focus on achieving cash flow breakeven “before the additional capital becomes needed.” Management said gross margins of “50% or more are achievable at scale,” targets availability in every state where the products are authorized and in “as many of the more than 272,000 U.S. retail locations that sell cigarettes as possible,” and identified a serviceable addressable market of “approximately $35 billion annually” within a U.S. tobacco market of “approximately $70 billion in annual sales,” including “roughly $50 billion” in cigarettes.

22nd Century Financial Statement Overview

Summary

Revenue improved and the balance sheet remains relatively sound with low debt, but negative gross profit, a $12.2 million net loss, and approximately $5.9 million of negative operating and free cash flow indicate substantial financial weakness.

Income Statement

15Very Negative

Balance Sheet

68Positive

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue12.78M7.05M11.88M32.20M40.50M30.95M
Gross Profit-1.32M-3.14M-2.40M-8.70M1.85M1.49M
EBITDA-10.61M-10.53M-12.11M-40.41M-32.89M-31.00M
Net Income-12.21M-5.05M-15.16M-140.78M-59.80M-32.61M
Balance Sheet
Total Assets23.36M27.02M21.67M27.50M114.65M75.95M
Cash, Cash Equivalents and Short-Term Investments3.91M7.15M4.42M2.06M20.40M48.74M
Total Debt1.47M4.21M8.62M16.38M4.65M2.34M
Total Liabilities7.28M11.27M17.66M35.91M18.68M9.88M
Stockholders Equity16.08M15.76M4.01M-8.41M95.97M66.07M
Cash Flow
Free Cash Flow-6.24M-8.60M-14.51M-60.60M-56.14M-23.91M
Operating Cash Flow-5.89M-7.72M-14.35M-54.99M-51.71M-22.84M
Investing Cash Flow-1.37M-505.00K-139.00K16.82M22.58M-27.73M
Financing Cash Flow6.32M10.96M16.85M37.21M30.82M50.88M

22nd Century Technical Analysis

Technical Analysis SentimentNegative
Last Price0.34

Price Trends

50DMA38.87Negative
100DMA130.32Negative
200DMA1386.43Negative

Market Momentum

MACD-11.71Negative
RSI16.33Positive
STOCH2.86Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XXII, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 2.93, below the 50-day MA of 38.87, and below the 200-day MA of 1386.43, indicating a bearish trend. The MACD of -11.71 indicates Negative momentum. The RSI at 16.33 is Positive, neither overbought nor oversold. The STOCH value of 2.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XXII.

22nd Century Risk Analysis

22nd Century disclosed 34 risk factors in its most recent earnings report. 22nd Century reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Nasdaq may delist our common stock from trading on its exchange, which could limit investors' ability to make transactions in our common stock, negatively impact the liquidity of our common stock and materially impair our ability to raise the additional capital necessary to continue our operations.Q3, 2026
2.Our securities are currently listed on the Nasdaq. If Nasdaq delists our securities from trading on its exchange, we could face significant material adverse consequences, including:Q3, 2024
3.Our securities are currently listed on the Nasdaq. If Nasdaq delists our securities from trading on its exchange, we could face significant material adverse consequences, including:Q2, 2024

22nd Century Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

XXII against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TPBTPB57Neutral$949.55M32.656.97%0.68%23.78%-51.37%
ISPRISPR47Neutral$73.36M-1.92165.45%―-21.35%2.18%
UVVUVV43Neutral$822.09M-322.30-0.17%10.24%-8.88%-102.19%
XXIIXXII42Neutral$219.19K0.00-68.11%―-15.53%99.45%
KAVLKAVL42Neutral$390.71K-0.02-9999.00%―-75.31%-17.46%
GNLNGNLN39Underperform$643.31K-0.00-249.60%―-57.94%99.51%

* Consumer Defensive Sector Average

Performance Comparison

-100%-50%0%50%XXIIUVVTPBGNLNKAVLISPRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
XXII and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
XXII22nd Century Group0.34-14493.88-100.00%
UVVUniversal Corporation32.23-16.21-33.46%
TPBTurning Point Brands Inc46.36-50.11-51.94%
GNLNGreenlane Holdings0.51-26.57-98.11%
KAVLKaival Brands Innovations Group Inc0.02-0.45-96.34%
ISPRIspire Technology, Inc.1.23-1.05-46.05%

22nd Century Corporate Events

Regulatory Filings and ComplianceStock Split

22nd Century Announces 1-for-58 Reverse Stock Split

Neutral
Nov 3, 2026

On November 3, 2026, 22nd Century Group announced a 1-for-58 reverse stock split as a measure to restore compliance with NASDAQ Capital Market continued-listing standards. The announcement set the effective time at 12:01 a.m. Eastern time on November...

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance

22nd Century Expands Sales Agreement, Adds Clear Street

Positive
Oct 28, 2026

On October 27, 2026, 22nd Century Group, Inc. amended its existing sales agreement originally executed with Needham & Company LLC on November 4, 2025 and previously amended on March 31, 2026. The new amendment adds Clear Street LLC as an additional s...

Private Placements and FinancingRegulatory Filings and Compliance

22nd Century Group Expands At-The-Market Stock Offering

Negative
Oct 23, 2026

On October 23, 2026, 22nd Century Group, Inc. filed a prospectus supplement with the Securities and Exchange Commission, enabling the company to sell up to $18.8 million of its common stock under an at-the-market offering through Needham & Company, L...

Business Operations and StrategyFinancial Disclosures

22nd Century Reports Strong Q3 Revenue and Profitability Gains

Positive
Oct 22, 2026

On October 22, 2026, 22nd Century Group preliminarily reported unaudited financial results for the third quarter ended September 30, 2026, highlighting sharp revenue growth and improved profitability metrics from continuing operations. Net revenue ro...

Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements

22nd Century Expands Low-Nicotine Cigarette Retail Footprint

Positive
Sep 1, 2026

In a mid-year shareholder letter dated September 1, 2026, 22nd Century reported progress in expanding its low-nicotine VLN® and Pinnacle cigarette brands, with products now in about 2,000 U.S. retail outlets and a goal of roughly 5,000 by year-end, i...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 20, 2026